Therefore, no recommendation exists concerning the surgical treatment of MEN1-related gastrinoma, and potential benefits of surgical indication should be weighted with the risk of an aggressive surgery and potential reoperations. The gene discussed is MEN1; the disease is gastrin-producing neuroendocrine tumor.